Alector, Inc. - Common Stock (NQ:ALEC)

1.970 +0.020 (+1.03%)

Delayed Quote Updated: 4:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alector, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week ↗

July 03, 2021

Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few...

Via Benzinga

Why Alector Blasted Higher Today ↗

July 02, 2021

It's not every day that a small biotech announces a major collaboration deal with a deep-pocketed pharmaceutical giant.

Via The Motley Fool

Mid-Afternoon Market Update: Silver Rises 2%; Alector Shares Spike Higher ↗

July 02, 2021

Toward the end of trading Friday, the Dow traded up 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose, gaining 0.66% to 4,348.47. The U.S. has the...

Via Benzinga

Topics Stocks

S&P 500 Logs Another Record High as "Fear Gauge" Dips ↗

July 02, 2021

Stocks are modestly in the black midday, thanks to upbeat monthly jobs data that showed 850,000 jobs were added in June.

Via Talk Markets

Topics Stocks

Don't Miss What Sent These 2 Little-Known Nasdaq Newsmakers Soaring ↗

July 02, 2021

One of these companies is making big waves.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 02, 2021

Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million...

Via Benzinga

Arrowhead Stock Plunges, Alector Stock Surges On Drug News ↗

July 02, 2021

Arrowhead paused a drug study; Alector teamed up with GlaxoSmithKline to develop two drugs. Arrowhead stock sank, while Alector stock surged.

Via Investor's Business Daily

Mid-Day Market Update: Dow Surges Over 100 Points; Arrowhead Pharmaceuticals Shares Plummet ↗

July 02, 2021

Midway through trading Friday, the Dow traded up 0.33% to 34,747.45 while the NASDAQ rose 0.50% to 14,594.85. The S&P also rose, gaining 0.47% to 4,340.12. The U.S. has the...

Via Benzinga

Topics Stocks

ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher ↗

July 02, 2021

Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK).

Via InvestorPlace

Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK ↗

July 02, 2021

Alector Inc (NASDAQ: ALEC) and GlaxoSmithKline plc (NYSE: GSK) have announced a global collaboration for the development and commercialization of two...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 02, 2021

Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 08, 2021

Gainers Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 37.46% to $4.33 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 9...

Via Benzinga

70 Biggest Movers From Yesterday ↗

May 06, 2021

Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters...

Via Benzinga

Stocks Mixed at Midday, Still on Track for Solid Weekly Gains ↗

April 09, 2021

The Dow is up roughly 75 points this afternoon.

Via Talk Markets

Topics Stocks

51 Biggest Movers From Friday ↗

April 12, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and...

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 09, 2021

Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.